Point of Care Molecular Diagnostics Market 2025: Agilent Technologies Inc., Abbott, F. Hoffmann-La Roche Ltd., Illumina Inc., Hologic Inc., QIAGEN, Myriad Genetics, Cepheid, Genomic Health, GenePOC Inc., DxNA LLC., Binx Health Inc.

Global Point of Care Molecular Diagnostics Market is estimated to rise from the value of USD 627.6 million in 2017 to an estimated value of USD 1933.2 million by 2025, registering a CAGR of 15.1% during the forecast period of 2018-2025.

Global Point of Care Molecular Diagnostics Market,
• By Product (Assays & Kits, Instruments/Analyzers, Services & Software),
• By Application (Respiratory Diseases, Sexually Transmitted Diseases, Hospital-acquired Infection, Oncology, Hepatitis, Others),
• By Technology (Polymerase Chain Reaction, In-Situ Hybridization, Chips and Microarrays, Mass Spectrometry, Sequencing, Isothermal Amplification, Others),
• By End-User (Physician Offices, Hospitals, Research Institutes, Others),
• By Geography (North America, South America, Europe, Asia-Pacific, Middle East & Africa)– Industry Trends & Forecast to 2025

Get Exclusive Sample PDF of Report at https://databridgemarketresearch.com/request-a-sample/?dbmr=global-point-of-care-molecular-diagnostics-market

The advancements and developments in the diagnostics market is attributed to the fact that the healthcare industry is focusing on detection and diagnosis in place of pharmaceuticals and medicines, to prevent the development of the diseases. This trend has directly affected the market growth and is helping the market to grow significantly.

North America had the highest revenue share of around 40% of the market.

Key Market Competitors:

Few of the major competitors currently working on the Point of Care Molecular Diagnostics Market are:-

• Agilent Technologies Inc.,
• Abbott, F. Hoffmann-La Roche Ltd.,
• Illumina Inc.,
• Hologic Inc.,
• QIAGEN,
• Myriad Genetics,
• Cepheid,
• Genomic Health,
• GenePOC Inc.,
• DxNA LLC.,
• Binx Health Inc.,
• Spartan Bioscience Inc.,
• Biocartis,
• Beckman Coulter Inc.,
• Johnson & Johnson Services Inc.,
• Medtronic, Siemens Healthcare GmbH,
• Grifols S.A.,
• Abaxis, Bayer AG,
• bioMérieux SA,
• Bio-Rad Laboratories Inc.,
• Danaher,
• OraSure Technologies Inc.,
• BD,
• Sysmex Corporation,
• Quidel Corporation, and
• Meridian Bioscience Inc.

Get Instant Discount | Contact us at https://databridgemarketresearch.com/inquire-before-buying/?dbmr=global-point-of-care-molecular-diagnostics-market

Market Drivers:

• Increasing cases of infectious diseases causing the health professionals to determine the infections and its causes accurately in a timely manner, thereby increasing the demand for Point of Care Molecular Diagnostics Market.
• Increased demand for regulatory approved molecular tests driving the market

Key Developments in the Market:

• In October 2017, Abbott completed the acquisition of Alere, for USD 5.9 billion. Alere was a global leader in diagnostics market and the acquisition helps Abbott grow its market share.
• In July 2017, Agilent Technologies announced the acquisition of Population Genetics’ molecular and sample barcoding patent portfolios which help improve the accuracy of next generation sequencing (NGS). These help in the diagnostics of cancer.

Table of Contents

1. Introduction
2. Market Segmentation
3. Market Overview
4. Executive Summary
5. Premium Insights
6. Global, By Component
7. Product Type
8. Delivery
9. Industry Type
10. Geography
10.1. Overview
10.2. North America
10.3. Europe
10.4. Asia-Pacific
10.5. South America
10.6. Middle East & Africa
11. Company Landscape
12. Company Profiles
13. Related Reports

Request for Detailed TOC at https://databridgemarketresearch.com/toc/?dbmr=global-point-of-care-molecular-diagnostics-market

About Data Bridge Market Research:

Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.

Contact:

Data Bridge Market Research
Tel: +1-888-387-2818
Email: sopan.gedam@databridgemarketresearch.com

This release was published on openPR.